← Home
🚀 Sign up Free for Company Insights & Valuation!
Sign up for free to get access to the best public company valuation and insights. Get started today and unlock the potential of your investments!
Sign up free
Agilent Technologies
-5.42%
Healthcare & biotech / Life Sciences and Diagnostics
At a Glance | Core Facts | Company Due Diligence | Industry Due Diligence | Competitors | Stock Swings | News | Income | Balance | Cash Flow | Growth | Enterprise | Ratios | Metrics | Dividends | Risks | SWOT | Porter's Five Forces | PEST | Score Positive | Clusters | Reports | WebCash Flow Statement
Pay attention and research significant changes from year to year values. [ ! ]
| Fixed Column | Net Income | Depreciation And Amortization | Deferred Income Tax | Stock Based Compensation | Change In Working Capital | Accounts Receivables | Inventory | Accounts Payables | Other Working Capital | Other Non Cash Items | Net Cash Provided By Operating Activities | Investments In Property Plant And Equipment | Acquisitions Net | Purchases Of Investments | Sales Maturities Of Investments | Other Investing Activities | Net Cash Used For Investing Activities | Debt Repayment | Common Stock Issued | Common Stock Repurchased | Dividends Paid | Other Financing Activities | Net Cash Used Provided By Financing Activities | Effect Of Forex Changes On Cash | Net Change In Cash | Cash At End Of Period | Cash At Beginning Of Period | Operating Cash Flow | Capital Expenditure |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10 | 1289.0 | 257.0 | -64.0 | 129.0 | 83.0 | 7.0 | 34.0 | 103.0 | -61.0 | 57.0 | 1751.0 | -378.0 | -862.0 | 0.0 | 0.0 | -18.0 | -1258.0 | 637.0 | 0.0 | -1150.0 | -274.0 | 65.0 | -752.0 | -2.0 | -261.0 | 1332.0 | 1593.0 | 1751.0 | -378.0 |
| 2023-10 | 1240.0 | 271.0 | -56.0 | 111.0 | -116.0 | 132.0 | -33.0 | -171.0 | -44.0 | 322.0 | 1772.0 | -298.0 | -1.0 | -8.0 | 5.0 | -8.0 | -310.0 | -35.0 | 0.0 | -575.0 | -265.0 | -55.0 | -930.0 | 5.0 | 537.0 | 1593.0 | 1056.0 | 1772.0 | -298.0 |
| 2022-10 | 1254.0 | 317.0 | 8.0 | 125.0 | -478.0 | -321.0 | -248.0 | 121.0 | -30.0 | 86.0 | 1312.0 | -291.0 | -52.0 | -13.0 | 22.0 | -4.0 | -338.0 | 26.0 | 58.0 | -1139.0 | -250.0 | -9.0 | -1372.0 | -36.0 | -434.0 | 1056.0 | 1490.0 | 1312.0 | -291.0 |
| 2021-10 | 1210.0 | 321.0 | 14.0 | 110.0 | -88.0 | -128.0 | -136.0 | 64.0 | 112.0 | -82.0 | 1485.0 | -189.0 | -546.0 | -22.0 | 12.0 | -4.0 | -749.0 | 356.0 | 0.0 | -788.0 | -236.0 | -28.0 | -696.0 | 3.0 | 43.0 | 1490.0 | 1447.0 | 1485.0 | -189.0 |
Wait! There's more — sign up for free or log in